Stock Events

Integra Lifesciences 

€19.8
5
+€0+0% Friday 06:06

Statistics

Day High
19.8
Day Low
19.8
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
1.65B
P/E Ratio
69.85
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23OctConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0.47
0.62
0.76
0.9
Expected EPS
0.472816
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IL3.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap124.93B
Stryker Corporation competes directly with Integra Lifesciences in the medical technology and surgical instruments sector, offering similar products for neurosurgery and orthopedics.
Medtronic
MDT
Mkt Cap105.2B
Medtronic plc offers a wide range of medical devices that compete with Integra's offerings, especially in the neurosurgery and spinal products market.
Johnson & Johnson
JNJ
Mkt Cap386.65B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical products and wound care, overlapping with Integra's product lines.
Zimmer Biomet
ZBH
Mkt Cap22.01B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and neurosurgery sectors, offering products that directly compete with Integra's surgical instruments and implants.
Boston Scientific
BSX
Mkt Cap112.2B
Boston Scientific Corporation offers products in the neuromodulation and neurovascular sectors, competing with Integra Lifesciences' neurosurgical product lines.
Globus Medical
GMED
Mkt Cap9.91B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic surgery products, competing with Integra's offerings.
Integra Lifesciences
IART
Mkt Cap1.65B
Integra Lifesciences competes with itself through its diverse range of products, constantly innovating and expanding its portfolio to stay competitive in the market.
Alphatec
ATEC
Mkt Cap886.3M
Alphatec Holdings, Inc. is a provider of spinal surgery solutions, competing in the same space as Integra Lifesciences with its focus on innovative spinal products and technologies.

Analyst Ratings

26.29Average Price Target
The highest estimate is €35.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
43%
Sell
57%

About

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Show more...
CEO
Dr. Stuart M. Essig Ph.D.
Employees
3946
Country
US
ISIN
US4579852082
WKN
000897013

Listings